For the year ending 2025-12-31, AVNS made $701,200K in revenue. -$72,900K in net income. Net profit margin of -10.40%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Net sales | 701,200 | |||
| Cost of products sold | 347,300 | |||
| Gross profit | 353,900 | |||
| Research and development | 23,300 | |||
| Selling and general expenses | 315,600 | |||
| Goodwill and intangibles impairment | 77,000 | |||
| Other (income) expense, net | 400 | |||
| Operating (loss) income | -61,600 | |||
| Interest income | 3,200 | |||
| Interest expense | 7,800 | |||
| Loss before income taxes | -66,200 | |||
| Income tax (provision) benefit | 6,700 | |||
| Loss from continuing operations | -72,900 | |||
| Loss from discontinued operations, net of tax | 0 | |||
| Net loss | -72,900 | |||
| Basic EPS | -1.57 | |||
| Diluted EPS | -1.57 | |||
| Basic Average Shares | 46,300,000 | |||
| Diluted Average Shares | 46,300,000 | |||
AVANOS MEDICAL, INC. (AVNS)
AVANOS MEDICAL, INC. (AVNS)